ARTICLE | Financial News

Kura raises $59.1M in an at-the-market financing

February 2, 2018 8:22 PM UTC

Cancer company Kura Oncology Inc. (NASDAQ:KURA) raised $59.1 million on Jan. 24 through the sale of 3.1 million shares at $18.85 in an at-the-market financing underwritten by Cowen.

Kura reported preliminary data in December from nine evaluable patients with wild-type RAS chronic myelomonocytic leukemia (CMML) in a Phase II trial showing that tipifarnib led to an overall response rate (ORR) of 33% (see BioCentury, Jan. 5)...

BCIQ Company Profiles

Kura Oncology Inc.

BCIQ Target Profiles

Farnesyl transferase